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Background
Placebo has an established role in pharmacological trials
but is rarely used to examine the efficacy of surgical
interventions. The aim of this study was to analyse the
efficacy of the crucial surgical element in comparison to
the placebo arm in randomised trials investigating surgi-
cal procedures.
Methods
We searched MEDLINE, EMBASE, and the Cochrane
Controlled Trials Register, from their beginning to
September 2012, and screened the references of the
already included studies. We reviewed randomised clini-
cal trials comparing surgery with a placebo intervention.
Surgery was defined as any procedure that changes the
anatomy and requires a skin incision or the use of endo-
scopic techniques; dental studies were excluded. We did
not limit the search to any particular type of interven-
tion or condition.
Results
We identified 96 relevant reports corresponding to 74
unique studies. Fifty-two trials were included into the
meta-analysis. In three quarters of the studies (38/52) an
improvement was reported in both arms and only in
half of the trials (25/52) the active treatment was more
effective than the placebo. The effect was generally in
favour of the active treatment but in many trials the dif-
ference was statistically significant only for some
outcomes.
Conclusions
Placebo-controlled randomised trials have a significant
value in assessing the absolute efficacy of surgery, espe-
cially when the outcomes are subjective and the likelihood
of a placebo effect is high. Interventions that are truly
effective and superior to placebo should be encouraged
and the procedures that are not more effective than
placebo should not be performed.
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